Alnylam Pharmaceuticals, Inc. (ALNY) Stock Prediction 2026
Alnylam Pharmaceuticals, Inc. is scored daily by TradeWell’s model ensemble. The TW Quant Score below is the model’s conviction percentile among 4,036 scored stocks on the 1Y horizon — one of 10 horizons (1D to 5Y) scored for every covered stock.
TW Quant Score is research, not investment advice. It is not a recommendation to buy or sell any security. Predictions can be wrong. Past model performance does not guarantee future results.
As of October 1, 2026, Alnylam Pharmaceuticals, Inc. ranks #2,172 of 4,036 scored stocks on the 1Y horizon.
Signal breakdown — as of October 1, 2026
Each signal is scored 0–100. A dash means the signal was not computed for ALNY on this scan — TradeWell discloses missing data rather than printing a fake zero.
| Trend | 58 |
| Momentum | 100 |
| Volume | 0 |
| Pattern | 100 |
| Insider activity | 50 |
| News sentiment | 52 |
| Seasonality | 47 |
| Macro / sector | 48 |
| Mean reversion | 3 |
| Fundamental | 70 |
Expected return and price target
Model expected returns and model-implied price targets for Alnylam Pharmaceuticals, Inc. across all 10 horizons are published in the app and refreshed daily. They are not reproduced on this page.
How this prediction is built
A multi-model ensemble (Ridge, XGBoost, LightGBM, and deeper research models) ranks 2,800+ stocks daily per horizon; predictions are tracked and graded against real outcomes. Method details: methodology. All Nasdaq-100 pages: index.